CYTOTOXIC EFFECT OF THE ETHANOLIC EXTRACT OF LOPHOCEREUS SCHOTTII: A MEXICAN MEDICINAL PLANT. by Orozco-Barocio, Arturo et al.
Orozco-Barocio et al., Afr J Tradit Complement Altern Med. (2013) 10(3):397-404 
http://dx.doi.org/10.4314/ajtcam.v10i3.2 
 
397
CYTOTOXIC EFFECT OF THE ETHANOLIC EXTRACT OF LOPHOCEREUS SCHOTTII: A 
MEXICAN MEDICINAL PLANT. 
 
Arturo Orozco-Barocio1*, Brenda Lizbeth Paniagua-Domínguez1, Pedro Alberto 
Benítez-Saldaña1, Edgardo Flores-Torales1, Salvador Velázquez-Magaña1  and  Hilda 
Julieta Arreola Nava2 
 
1 Laboratory of Immunobiology, Department of Cellular and Molecular Biology. University 
Center of Biological and Agricultural Sciences. University of Guadalajara. Km 15.5 carretera 
Guadalajara – Nogales, Las Agujas, Nextipac, Zapopan, Jalisco, México. CP: 44100. 
2 Institute of Botany, Department of Botany and Zoology.University Center of Biological and 
Agricultural Sciences. University of Guadalajara. Km 15.5 carretera Guadalajara – Nogales, 
Las Agujas, Nextipac, Zapopan, Jalisco, México. CP: 44100. 
 
* Correspondence to: A. Orozco-Barocio, Laboratory of Immunobiology. University Center of 
Biological and Agricultural Sciences, Phone: (52) 33 3777-1150 ext. 33230. Fax (52) 33 
3777-1159. University of Guadalajara. Carretera Guadalajara – Nogales Km 15.5. Las 
Agujas, Nextipac, Zapopan, Jalisco, México. CP: 44100. 
*Email: arorozcob@prodigy.net.mx, arorozco@cucba.udg.mx  
 
 
 
 
Abstract 
 
Lophocereus schottii is a Mexican cactus known as garambullo whose bark is used for the treatment of 
cancer, diabetes, ulcers, sores, stomach disorders and tuberculosis. The aim of this study was to evaluate the 
cytotoxic effect of the ethanolic extract of bark of L. Schottii. To assess these effects we established a flow of 
experiments in a model of BALB/c mice murine lymphoma. We value first survival of mice inoculated with 2 × 104 
L5178Y murine lymphoma cells, orally treated with 10 mg/Kg of the extract for 10 consecutive days; the second 
assessment was to determine the influence of the immune system, we carry out studies of lymphoproliferation in 
mice with the same conditions of the previous study, only that the treatment was for 22 days before the 
completion  cell cultures; the third study was to establish the cytotoxic effect of extract of L. schottii using different 
concentrations, by murine lymphoma cell cultures and splenocytes from healthy mice and finally we assessed the 
effect in vivo of extract of L. Schottii  in a model of solid murine  lymphoma inoculating 1 x 107 lymphoma cells in 
the gastrocnemius muscle observing the development of the tumor. We observed that oral treatment of 10 mg/kg 
of extract of L. schottii increased survival rate in treated mice; additionally, an intratumoral injection of 50 and 100 
mg/kg in a solid murine lymphoma located in the gastrocnemius muscle, allowed a significantly slower tumor 
evolution. In vitro studies determined that extract inhibited 63% of lymphoma cell growth. With these evidences it 
is feasible to scientifically validate that ethanolic extract of L. schottii had an effect on L5178Y murine cells 
lymphoma and could have the same effect in human tumors. 
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Introduction 
 
              The medicinal plants are a common alternative for cancer treatment in many countries, approximately 
60% of drugs currently used for cancer treatment have been isolated from natural products (Gordaliza, 2007) ; in 
Mexico, 30 to 70% of diagnosed patients with cancer use herbal extracts as an alternative therapy for several 
types of cancer (Gerson-Cwilich  et al., 2006; Gomez-Martinez et al., 2007). Plant extracts have been an 
important source of anticancerogenous agents used in medicine (Saklani, 2008; Jacobo-Salcedo et al., 2011), 
and Mexican medicinal plants play an important role in new treatment research (Alonso-Castro et al., 2011).  
             Lophocereus schottii (Engelm) Britton & Rose is a cactus which grows to 2 - 4 m tall, has 5 to 10 ribs, is 
an endemic species of Mexico, warm weather, associated with coastal dunes and xerophyl shrublands, found in 
Northwestern from Mexico and Arizona desert in United States of America; It’s common names include cardona, 
muso, sina, sinita, cactus star and garambullo. L. schottii is traditionally used for treatment of cancer, diabetes, 
ulcers, sores, stomach disorders and tuberculosis (Argueta-Villamar et al., 1994; Encarnación-Dimayuga et al., 
1987; Bravo-Hollis, 1999). However, there are no scientific studies demonstrating its anticancer activity. Alonso-
Castro et al. (2011), in their study on 300 Mexican medicinal plants, recorded L. schottii in the group of plants that 
Orozco-Barocio et al., Afr J Tradit Complement Altern Med. (2013) 10(3):397-404 
http://dx.doi.org/10.4314/ajtcam.v10i3.2 
 
398
refer ethnopharmacological uses against cancer, without scientifically based research (Alonso-Castro et al., 
2011). 
 
Considering that the cytotoxic and immunomodulation effects of L. schottii are unexplored, the objective of this 
study is to evaluate in vivo and in vitro the ethanolic extract effect of the stem of L. schottii on a murine lymphoma 
model. We value first survival of mice inoculated with 2 × 104 L5178Y murine lymphoma cells, orally treated with 
10 mg/Kg of the extract for 10 consecutive days; the second assessment was to determine the influence of the 
immune system, we carry out studies of lymphoproliferation in mice with the same conditions of the previous 
study, only that the treatment was for 22 days before of completion cell cultures; the third study was to establish 
the cytotoxic effect of ethanolic extract of L. schottii using different concentrations (125, 62.5, 31.25, 15.65, 7.81 y 
0.97 µg/ml) by L5178Y murine lymphoma cell cultures and splenocytes from healthy mice and finally we assessed 
the effect in vivo of extract of L. Schottii  in a model of solid murine  lymphoma inoculating 1 x 107 lymphoma cells 
in the gastrocnemius muscle observing the development of the tumor.  
 
 
Material and Methods 
Plant materials and extraction and preparation of ethanol extract 
 
Lophocereus schottii (Engelm) Britton & Rose was collected in July 2008 from Desert of Sonora, Mexico 
and identified by Dra. Hilda Julieta Arreola Nava (Institute of Botany University of Guadalajara). A voucher sample 
has been deposited in the Herbarium of Botany Department of University of Guadalajara under the number IBUG-
189957. Stem from L. schottii (400g) was cut and dried into small pieces and extracted with ethanol absolute 
placing 10 g of powder in 100 ml absolute ethanol (1:10, w/v) under shaking for 48 h at room temperature in 
darkness. The extract was filtered and concentrated under reduced pressure in a rotary evaporator (MOD. RE47, 
Yamato Scientific CO LTD. Tokyo, Japan), and lyophilized (Freezone 4.5, Labconco, Kansas City, MO), finally the 
dry powder was resuspended in injectable water or culture medium AIM-V (GIBCO BRL, Grand Island, NY, USA) 
according to the in vivo or in vitro treatment respectively and sterilized by filtering through a 0.22 µm membrane 
(Acrodisc Siringe Filters Pall Corporation, Ann Arbor, MI).  
 
 
Animals  
 
Male BALB/c mice aged 6–8 weeks were maintained and bred under conventional laboratory conditions 
at the University of Guadalajara, Guadalajara, Mexico, according to the guidelines for the use and care of 
laboratory animals and World Medical Association Declaration of Helsinki (amended by the 52nd WMA General 
Assembly, Edinburgh, Scotland, October 2000). Animal protocols were approved by the Biomedicine Sciences 
Committee. 
 
Lymphoma cell line 
 
The murine lymphoma cell line L5178Y was derived from murine thymic lymphoma of DBA/2 mice (H-
2d/d), and was maintained in ascetic form by weekly intraperitoneal (i.p.) passages of 1 x 106 cells in syngenic 
BALB/c mice (H-2d/d) (Perez-Puebla, 1998). 
 
Lethal dose (LD50) 
 
Oral single doses from ethanolic extract  from L. Schottii (50, 500 and 5000 mg/Kg body weight) were 
administered in mice from three independent groups (n = 10 each) for the LD50 determination. The mice were kept 
in observation for 90 days to record clinical signs of acute toxicity such as, postration change behavior, respiratory 
and motor disturbances, piloerection and death (Loomis, 1982; Kent, 1998).  
 
Studies on survival rate of mice with L5178Y lymphoma 
 
            The antitumor activity of ethanolic extract of L. schottii was evaluated in vivo using survival time (survival 
%) of mice inoculated with 2 x 104 cells of L5178Y murine lymphoma by intraperitoneal route and treated orally 
with 10 mg/kg daily, at the following day of tumor implantation for 10 days; mice were daily kept under observation 
to assess their general conditions and record the day of death. The survival time was valuated and represented 
with Kaplan- Meier curves of survival.  
 
Lymphoproliferation with ex vivo MTT   
  
            In order to determine whether cell type immune response, in this murine lymphoma model, was modified 
by action of ethanolic extract of L. schotti, four experimental groups of 5 mice each were used. Two groups were 
inoculated intraperitoneally with 2 × 104 L5178Y murine lymphoma cells; one of them was treated with 10 mg/kg 
of ethanolic extract diluted in injectable water, and the other group only received injectable water (100 µl). The 
other 2 groups were also inoculated with only injectable water into the peritoneal cavity (100 µl), one of them also 
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was treated with 10 mg/kg of ethanolic extract L. schotti. The four groups were treated for 22 consecutive days by 
oral route and after they were euthanized to obtain spleen cells, and lymphoproliferation assay was performed by 
using MTT method, according to the Hansen technique (Hansen, 1989), briefly: Concanavalin A (Sigma 
Chemical, St. Louis, MO) was used as mitogenic stimulus, the spleens were removed aseptically; cell proliferation 
was measured using 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT). The method involves 
conversion of MTT to coloured formazan by the living cells. Then, 40 μl of MTT (5 mg/ml) was added to each well. 
After 2 h incubation at 37o C, 160 μl of extraction buffer pH 4.7 containing 20% w/v of SDS (Bio-Rad, Richmond, 
CA) in a solution of 50% N,N-dimethyl formamide (Sigma Chemical, St Louis, MO) in demineralized water were 
added. After overnight incubation at 37 o C, optical densities at 570 nm were measured with an ELISA plate reader 
using the extraction buffer as blank. Cellular proliferation was determinated by Stimulation Index (SI) according to 
the following formula:  
SI = (Optical Density with mitogen/ Optical Density without mitogen). 
 
The proliferation index was statistically evaluated using the Kruscal-Wallis test. 
 
Citotoxicity assay 
 
In order to determine the direct in vitro effect of extract ethanolic on tumor cells growth and healthy 
spleen cells growth; L5178Y cells were collected from peritoneal liquid of mice bearing lymphoma and the cellular 
suspension obtained were washed three times with PBS solution and adjusted to 5 x 103 cell/well with AIM-V 
medium; in addition, spleen cells were obtained from healthy mice and seeded to flat bottom 96 well plates (4 x 
105 cells/well) (Corning Incorporated, NY, USA), cultures were performed in triplicate,  spleen cells were or not 
stimulated with 5 µg of Concanavalin A. All cultures (lymphoma cells, spleen cells with or without Concanavalin A) 
were incubated in the presence or absence of various concentrations of the extract ethanolic of L. schottii (125, 
62.5, 31.25, 15.65, 7.81, 0.97 and 0.0 µg/ml). The culture assay was performed with colorimetric technique of 
MTT (Hansen, 1989, described above) and the optical density (OD) was measured at 570 nm in a microplate 
reader (OPSYS MR, Dynex Technologies, Inc. Chantilly, VA, USA). The viability of the culture cells was estimated 
from the relative growth as follows:  % Citotoxicity = 100 – [(OD treated cells/OD not treated cells) x 100].  
 
Inhibition of tumor development in solid phase 
 
L5178Y cells were collected from peritoneal liquid of mice bearing lymphoma and the cellular suspension 
obtained were washed three times with PBS solution and adjusted to 1 x 107 cell/ml with AIM-V medium; four 
experimental groups of 10 mice each were used, all mice were inoculated with 100 µl of cellular suspension 
(1x106 lymphoma cells) in the left gastrocnemius muscle; two groups were treated with 50 (group 1) and 100 
mg/Kg (group 2) of ethanolic extract of L. schottii diluted in injectable water by intratumoral route, other group 
(group 3) was treated with 100 mg/Kg of ethanolic extract by intramuscularly route and the last group (control 
group) was not treated. The four groups were treated for 30 consecutive days, 48 hours after tumor administration 
of lymphoma. Tumor volume was measured once every day using a caliper (Digimatic Caliper Mitutoyo 
Corporation, Japan), one day before the inoculated lymphoma cells and during 30 days. Tumor volumen was 
estimated according to the following formula: tumor volumen (mm3) = (length x width2)/2. 
 
Statistical analysis 
 
Experimental values are expressed for in vivo antitumor activity was evaluated by survival time with 
Kaplan-Meier curves; for lymphocyte proliferation ex vivo assay was evaluated by Kruscal-Wallis test; for 
cytotoxicity assay and inhibition of tumor development in solid phase were evaluated by Honestly Significant 
Difference Test of Tukey. The level of p < 0.05 was used to determine statistical significance. All calculations were 
performed using the Excel Statistical Microsoft Corporation Software. 
 
 
Results  
Lethal-dose 50 (LD50)  
 
The ethanolic extract from L. schottii showed not lethal effects at doses (50-5000 mg/Kg body weight). 
Animals were observed until 90 days after administration. However, these animals did not die or behavioral and 
physiological alterations established by the toxicology standards, for more than 90 days of observation (Loomis, 
1982; Kent, 1998). 
 
Studies on survival rate of mice with L5178Y lymphoma 
 
            In order to determine the antitumor effect of ethanolic extract of L. schottii, 2 × 104 cells of L5178Y 
lymphoma were administered to two groups of mice (n = 10 for each one) in the peritoneal cavity, and one of the 
groups was treated with 10 mg/kg of ethanolic extract dissolved in injectable water by oral route, for the first 10 
days after tumor administration; the other group only received the same sterile injectable water volume (100 µl), 
they were kept under observation until they died and the survival rate of each group was determined. Kaplan-
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Meier statistical test revealed that the survival rate increased significantly (33 days) in mice treated with L. schottii 
compared with the non-treated group (28 days) (Figure 1).  
 
Figure 1: Antitumor effect of ethanolic extract of L. schottii evaluated by survival of mice with L5178Y murine 
lymphoma. Comparison of groups with or without the following treatment: 10 mg/kg/day/10 days (n = 10). 
The estimation of survival was significantly different P < 0.05 evaluated by the Kaplan-Meier test. 
 
Lymphoproliferation with ex vivo MTT   
 
            It is known that L5178Y murine lymphoma model produces immunosuppression in treated mice with 1 × 
107 cells (intraperitoneal route) at the sixth day of development (Oronzo-Barocio et al., 1999; Daneri-Navarro et 
al., 1995). In order to explain the survival increase due to L. schottii immunomodulator effect, in vitro tests of 
splenocyte lymphoproliferation were conducted in mice inoculated in the peritoneal cavity with 2 × 104 cells of 
L5178Y murine lymphoma for 22 days (2 groups n = 5). One of the groups was treated with 10 mg/kg of ethanolic 
extract of L. schottii diluted in sterile injectable water administered by oral route for 22 days; the other groups only 
received the vehicle (sterile injectable water) for the same period of time; lymphoproliferation tests were also 
conducted in two other groups of mice (n = 5 for each one) that did not received lymphoma cells and only 
ethanolic extract of L. schottii and vehicle were administered as previously described. MTT colorimetric assay was 
used to evaluate lymphoproliferation (Hansen, 1989). No significant difference (Kruskal-Wallis test) was observed 
between the 4 groups in regard to lymphoproliferation rate (Figure 2), which reveals that ethanolic extract of L. 
schottii has no effect on splenocyte proliferation of mice treated or not with the extract and survival increase can 
be explained by a direct cytotoxic action against murine lymphoma cells. 
 
 
 
Figure 2: Effect of ethanolic extract of L. schottii on lymphoproliferation of mice with L5178Y murine lymphoma 
with or without the following treatment: 10 mg/kg/day/22 days (n = 5). There was no significant difference 
in proliferation indexes evaluated by the Kruskal-Wallis test. 
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Cytotoxicity assay 
 
             Based on the previous results, the cytotoxic effect of ethanolic extract of L. schottii was determined using 
different concentrations (125, 62.5, 31.25, 15.65, 7.81 and 0.97 µg/ml), by L5178Y murine lymphoma cell cultures 
and splenocytes from healthy mice stimulated or not with Concanavalin-A (5 µg/ml). Plant extracts with 
cytotoxicity values of ED50 (Effective Dose 50) ≤ 30 µg/ml are considered active according to the parameters 
established by The National Cancer Institute (NCI) (Suffiness, 1990).  According to these criteria, the ethanolic 
extract of L. schottii has toxic effects on L5178Y lymphoma cells (ED50 = 7.8 g/ml with 63% of cytotoxicity); 
whereas, in splenocytes not stimulated with concanavalin-A from healthy mice, there was lower cytotoxic effect 
using the same concentration (38% of cell cytotoxicity, ED50 > 125 g); however, the splenocytes stimulated with 
concanavalin-A experienced 80% of cytotoxicity (Table 1 and Figure 3).  
 
 
Table 1.Effect of ethanolic extract of L. schottii on the cytotoxicity percentage of L5178Y murine lymphoma cells, 
healthy splenocytes and healthy splenocytes stimulated with Con-A. 
Concentration of 
ethanolic extract µg/ml 
L5178Y Lymphoma Cells Healthy Cells without 
Con-A  
Healthy Cells with Con-A 
125 
 
57 43 77 
62.5 
 
58 44 78 
31.25 
 
58 42 80 
15.63 
 
62 40 80 
7.8 
 
63 38 80 
3.9 
 
43 9 71 
1.95 
 
16 -8 61 
0.97 2 -17 57 
 
 
 
Figure 3: Effect of ethanolic extract of L. schottii on the cytotoxicity percentage of L5178Y murine lymphoma 
cells, healthy splenocytes and healthy splenocytes stimulated with Con-A. The cytotoxicity percentage, 
evaluated by Tukey’s multiple comparison test, was significantly different P < 0.05.  
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Inhibition of tumor development in solid phase 
 
             With these results, the in vivo cytotoxic effect of ethanolic extract of L. schottii was studied on a solid 
L5178Y murine lymphoma model, implanted in the left gastrocnemius of mice (1 x 106 cells), treated with 
ethanolic extract of L. schotti with daily doses of 50 and 100 mg/kg by intratumoral route and 100 mg/kg 
intramuscularly, starting 48 hours after first lymphoma inoculation. The development of the tumor volume, valued 
in mm3, was slower in groups treated with ethanolic extract of L. schottii than in non-treated group, mostly in the 
group that received 50 mg/kg by intratumoral route. Likewise, there was no difference in the extract administration 
route (Tukey´s multiple comparison test) (Figures 4 and 5). 
 
 
 
Figure 4: Effect of ethanolic extract of L. schottii on tumor growth (mm3) in mice with L5178Y murine lymphoma 
implanted in gastrocnemius muscle, with or without treatment by intratumoral (IT) and intramuscular (IM) 
route, n=10. Tumor growth, evaluated by Tukey´s multiple comparison test, was significantly different P < 
0.05. 
 
 
 
 
Figure 5: Hind leg of a healthy mouse (left), another inoculated with L5178Y murine lymphoma in the 
gastrocnemius muscle at 30 days of evolution, without treatment (right), and with 50 mg/kg of ethanolic 
extract of L. schottii (center)  by intratumoral route. 
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Discussion 
 
              The results demonstrate unequivocally, the cytotoxic effect of ethanolic extract of L. schottii on cells 
undergoing mitosis (L5178Y murine lymphoma cells and splenocytes stimulated with Concanavalin-A), this 
cytotoxic effect being significantly different with regard to healthy splenocytes in resting stage of mitosis or not 
stimulated, as shown in Figure 3 and Table 1. Likewise, it can be observed that the tumor volume in solid state, is 
smaller when ethanolic extract treatment is administered (Figure 5), demonstrating that the dose of 100 mg/kg 
both intratumorally and intramuscularly injected, show the same effect with regard to tumor volume reduction; 
however, between 50 and 100 mg/kg treatments using the same route of administration, it, indeed, showed 
differences with respect to the tumor volume (Figure 4).  
             In summary, these results provide important biological data that ethanolic extract of Lophocereus schottii 
effect, has important implications in the ethnomedicinal use against tumor cells, since it has significantly greater 
cytotoxic effect on L5178Y murine lymphoma cells than in healthy splenocytes, allowing survival increase in 
treated mice, decrease in solid lymphoma growth and mitosis interference. References found stated that whole 
plant and stem contain alkaloids of Isoquinoline, Lophocerine and Pilocereine (Wani et al, 1980; Kircher,  1969), 
as well as triterpenes Lophenol and Lupeol, and sterol Schottenol (Argueta-Villamar et al., 1994). It is known that 
generally derived alkaloids such as the isoquinoline compounds have anti-cancer effects and reduce tumors 
development (Wang et al., 2009; Pettit et al., 2009; Li et al., 2009; Stærk et al., 2002); likewise, a number of 
triterpenoids have shown promise as antineoplastic agents  and exhibit antiproliferative activity when tested 
against various cancer cell lines. Recent reports showed that triperpenes directly inhibit tumor growth, cell cycle 
progression and induce the apoptosis of tumor cells under in vitro and in vivo situations. (Palanimuthu et al., 
2012; Misawa et al., 2012; Siddique et al., 2011; He et al., 2011; Saleem, 2009). On the other hand the schottenol 
presents anticarcinogenic properties (Khallouki et al., 2003; Arisawa et al., 1985).  However, there is no 
information about the chemical derivatives of the generic compounds found in L. schottii. Therefore, it is 
necessary to conduct more phytochemical studies for isolation and identification of the active components of L. 
schottii. Likewise, further studies on the mechanisms of biological effects by which the extract exerts its anititumor 
effects are unavoidable. 
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